The african middle east association of gastroenterology (AMAGE) clinical practice guidelines for the diagnosis and management of metabolic dysfunction associated fatty liver disease

Basit Öğe Kaydı
dc.authorid0000-0001-8460-1185
dc.authorid0000-0002-3830-9236
dc.authorid0000-0003-2427-210X
dc.authorid0000-0002-1611-3451
dc.authorid0000-0002-6120-1055
dc.authorid0000-0003-2741-0440
dc.authorid0000-0002-8909-2102
dc.contributor.authorFouad, Yasser
dc.contributor.authorElwakil, Reda
dc.contributor.authorSanai, Faisal M.
dc.contributor.authorOjo, Olusegun
dc.contributor.authorAl Awadhi, Sameer
dc.contributor.authorOcama, Ponsiano
dc.contributor.authorAbdelaty, Nadia
dc.contributor.authorAl-Busafi, Said A.
dc.contributor.authorÖrmeci, Necati
dc.contributor.authorEslam, Mohammed
dc.date.accessioned2026-01-14T13:41:34Z
dc.date.available2026-01-14T13:41:34Z
dc.date.issued2026
dc.departmentFakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalı
dc.description.abstractOver the past few decades, the profile of liver diseases in Africa and the Middle East has undergone significant changes. The incidence of metabolic dysfunction-associated fatty liver disease (MAFLD) has risen to alarming levels. Despite the seriousness of the situation, there is a scarcity of local or regional guidelines established to address it. This document presents the clinical practice guidelines from the African Middle East Association of Gastroenterology (AMAGE) related to the screening, diagnosis, and management of MAFLD. It addresses multiple aspects of managing this condition while taking into account local circumstances and the healthcare system's management requirements. These guidelines are intended for routine clinical use, with a specific focus on particular groups when needed.
dc.identifier.citationFouad, Y., Elwakil, R., Sanai, F. M., Ojo, O., Al Awadhi, S., Ocama, P., Abdelaty, N., Al-Busafi, S. A., Örmeci, N., & Eslam, M. (2026). The african middle east association of gastroenterology (AMAGE) clinical practice guidelines for the diagnosis and management of metabolic dysfunction associated fatty liver disease. Annals of Hepatology, pp. 1-56. https://doi.org/10.1016/j.aohep.2026.102180
dc.identifier.doi10.1016/j.aohep.2026.102180
dc.identifier.endpage56
dc.identifier.issn2659-5982
dc.identifier.issn1665-2681
dc.identifier.pmidPMID: 41520698
dc.identifier.scopusqualityQ1
dc.identifier.startpage1
dc.identifier.urihttps://doi.org/10.1016/j.aohep.2026.102180
dc.identifier.urihttps://hdl.handle.net/20.500.13055/1243
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.indekslendigikaynak.otherSCI-E - Science Citation Index Expanded
dc.institutionauthorÖrmeci, Necati
dc.institutionauthorid0000-0002-8909-2102
dc.language.isoen
dc.publisherElsevier
dc.relation.ispartofAnnals of Hepatology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectMAFLD
dc.subjectGuidelines
dc.subjectFatty Liver
dc.subjectAMAGE
dc.titleThe african middle east association of gastroenterology (AMAGE) clinical practice guidelines for the diagnosis and management of metabolic dysfunction associated fatty liver disease
dc.typeArticle
dspace.entity.typePublication

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Kapalı Erişim
İsim:
Tam Metin / Full Text
Boyut:
1.56 MB
Biçim:
Adobe Portable Document Format
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
Kapalı Erişim
İsim:
license.txt
Boyut:
1.17 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Dahili Tıp Bilimleri Bölümü Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu